Skip to main content
Erschienen in: Annals of Surgical Oncology 3/2011

01.03.2011 | Breast Oncology

Breast Cancer Surgery Trend Changes Since the Introduction of BRCA1/2 Mutation Screening: A Retrospective Cohort Analysis of 158 Mutation Carriers Treated at a Single Institution

verfasst von: Angela Mislowsky, MD, Susan Domchek, MD, Cecilia Stroede, MD, Meredith R. Bergey, MS, Seema S. Sonnad, PhD, Liza Wu, MD, Julia Tchou, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

Background

Bilateral mastectomy in women diagnosed with unilateral breast cancer is on the rise in the USA. One contributing factor is increased awareness of contralateral breast cancer risk. Positive testing for deleterious mutation in BRCA1/2 is a concrete measure of this contributing factor. We hypothesize that breast cancer surgery trend change is temporally associated with the introduction of BRCA1/2 genetic testing around 1996.

Methods

Our study cohort included 158 BRCA1 or BRCA2 mutation carriers diagnosed with unilateral breast cancer between 1963 and 2009. Mutation carriers with ovarian cancer or bilateral breast cancer were excluded. Breast surgery and breast reconstruction surgery trends were analyzed according to year of breast cancer diagnosis or when bilateral mastectomy was performed, respectively.

Results

Surgery trends changed significantly over time. We observed a significant drop in the rate of unilateral mastectomy (P < 0.001) after the period 1996–2000, and the rate of bilateral mastectomy appears to be on the rise, up to 30.3% between 2006 and 2009. Breast reconstruction trends also changed significantly over time, with a significant rise in the rate of free flap reconstruction to 58.8% between 2006 and 2009.

Conclusions

Our results demonstrated a significant decrease in unilateral mastectomy with a rise in bilateral mastectomy after the period 1996–2000, a period which encompassed the year when genetic testing of the two BRCA1/2 genes became commercially available, hence supporting our hypothesis.
Literatur
1.
Zurück zum Zitat Tuttle T, Habermann E, Grund E, et al. Increasing use of contralateral prophylactic mastectomy among breast cancer patients: a trend toward more aggressive surgical treatment. Ann Surg Oncol. 2007;14(2 supplement):7. Tuttle T, Habermann E, Grund E, et al. Increasing use of contralateral prophylactic mastectomy among breast cancer patients: a trend toward more aggressive surgical treatment. Ann Surg Oncol. 2007;14(2 supplement):7.
2.
Zurück zum Zitat Tuttle TM. Management of the contralateral breast in women with breast cancer. Cancer Res. 2009;69 (Suppl.)(2):62s. Tuttle TM. Management of the contralateral breast in women with breast cancer. Cancer Res. 2009;69 (Suppl.)(2):62s.
3.
Zurück zum Zitat Throckmorton AD, Esserman LJ. When informed, all women do not prefer breast conservation. J Clin Oncol. 2009;27(4):484–6.PubMedCrossRef Throckmorton AD, Esserman LJ. When informed, all women do not prefer breast conservation. J Clin Oncol. 2009;27(4):484–6.PubMedCrossRef
4.
Zurück zum Zitat Sorbero ME, Dick AW, Beckjord EB, Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16(6):1597–605.PubMedCrossRef Sorbero ME, Dick AW, Beckjord EB, Ahrendt G. Diagnostic breast magnetic resonance imaging and contralateral prophylactic mastectomy. Ann Surg Oncol. 2009;16(6):1597–605.PubMedCrossRef
5.
Zurück zum Zitat Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345(3):159–64.PubMedCrossRef Meijers-Heijboer H, van Geel B, van Putten WL, et al. Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. N Engl J Med. 2001;345(3):159–64.PubMedCrossRef
6.
Zurück zum Zitat Tuttle TM. Magnetic resonance imaging and contralateral prophylactic mastectomy: the “no mas” effect? Ann Surg Oncol. 2009;16(6):1461–2.PubMedCrossRef Tuttle TM. Magnetic resonance imaging and contralateral prophylactic mastectomy: the “no mas” effect? Ann Surg Oncol. 2009;16(6):1461–2.PubMedCrossRef
7.
Zurück zum Zitat Press N, Reynolds S, Pinsky L, et al. ‘That’s like chopping off a finger because you’re afraid it might get broken’: disease and illness in women’s views of prophylactic mastectomy. Soc Sci Med. 2005;61(5):1106–17.PubMedCrossRef Press N, Reynolds S, Pinsky L, et al. ‘That’s like chopping off a finger because you’re afraid it might get broken’: disease and illness in women’s views of prophylactic mastectomy. Soc Sci Med. 2005;61(5):1106–17.PubMedCrossRef
8.
Zurück zum Zitat Stolier AJ, Fuhrman GM, Mauterer L, et al. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation. Breast J. 2004;10(6):475–80.PubMedCrossRef Stolier AJ, Fuhrman GM, Mauterer L, et al. Initial experience with surgical treatment planning in the newly diagnosed breast cancer patient at high risk for BRCA-1 or BRCA-2 mutation. Breast J. 2004;10(6):475–80.PubMedCrossRef
9.
Zurück zum Zitat Schwartz MD, Lerman C, Brogan B, et al. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol. 2004;22(10):1823–9.PubMedCrossRef Schwartz MD, Lerman C, Brogan B, et al. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. J Clin Oncol. 2004;22(10):1823–9.PubMedCrossRef
10.
Zurück zum Zitat Weitzel JN, McCaffrey SM, Nedelcu R, et al. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg. 2003;138(12):1323–8; discussion 1329.PubMedCrossRef Weitzel JN, McCaffrey SM, Nedelcu R, et al. Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Arch Surg. 2003;138(12):1323–8; discussion 1329.PubMedCrossRef
11.
Zurück zum Zitat Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst. 2002;94(20):1564–9.PubMed Metcalfe KA, Narod SA. Breast cancer risk perception among women who have undergone prophylactic bilateral mastectomy. J Natl Cancer Inst. 2002;94(20):1564–9.PubMed
12.
Zurück zum Zitat Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–9.PubMedCrossRef Tuttle TM, Habermann EB, Grund EH, et al. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment. J Clin Oncol. 2007;25(33):5203–9.PubMedCrossRef
13.
Zurück zum Zitat Metcalfe KA, Lubinski J, Ghadirian P, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol. 2008;26(7):1093–7.PubMedCrossRef Metcalfe KA, Lubinski J, Ghadirian P, et al. Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: the Hereditary Breast Cancer Clinical Study Group. J Clin Oncol. 2008;26(7):1093–7.PubMedCrossRef
Metadaten
Titel
Breast Cancer Surgery Trend Changes Since the Introduction of BRCA1/2 Mutation Screening: A Retrospective Cohort Analysis of 158 Mutation Carriers Treated at a Single Institution
verfasst von
Angela Mislowsky, MD
Susan Domchek, MD
Cecilia Stroede, MD
Meredith R. Bergey, MS
Seema S. Sonnad, PhD
Liza Wu, MD
Julia Tchou, MD, PhD
Publikationsdatum
01.03.2011
Verlag
Springer-Verlag
Erschienen in
Annals of Surgical Oncology / Ausgabe 3/2011
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-010-1381-9

Weitere Artikel der Ausgabe 3/2011

Annals of Surgical Oncology 3/2011 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.